Panel Discussion | Exploring the State of Play with Rezdiffra’s Approval
Time: 8:30 am
day: Conference Day 1 AM
Details:
- Discussing the impact of Rezdiffra on the therapeutic treatment of MASH
- Assessing how clinical trials and other drug classes are affected
- How will the standard of care be impacted?
